{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:38:12Z","timestamp":1790915892642,"version":"4.1.0"},"reference-count":69,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:p>\n            Methicillin-resistant\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            (MRSA) bloodstream infections (BSI) are associated with substantial morbidity and mortality. Monotherapy with first-line antimicrobials such as vancomycin (VAN; glycopeptide) and daptomycin (DAP; lipopeptide) are inadequate in some cases due to reduced antibiotic susceptibilities or therapeutic failure. In recent years, \u03b2-lactam antibiotics have emerged as a potential option for combination therapy with VAN and DAP that may meet an unmet therapeutic need for MRSA BSI.\n          <\/jats:p>","DOI":"10.1128\/aac.00468-20","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T15:04:59Z","timestamp":1587395099000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["The Emerging Role of \u03b2-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-5984","authenticated-orcid":false,"given":"Kyle C.","family":"Molina","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA"},{"name":"Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-043X","authenticated-orcid":false,"given":"Taylor","family":"Morrisette","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA"},{"name":"Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA"},{"name":"Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-3554","authenticated-orcid":false,"given":"Vanthida","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Midwestern University College of Pharmacy\u2013Glendale, Glendale, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas N.","family":"Fish","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"2112","article-title":"Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States","volume":"69","author":"Inagaki K","year":"2019","unstructured":"Inagaki K, Lucar J, Blackshear C, Hobbs CV. 2019. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 69:2112\u20132118.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz498"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00775-12"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1079-1082.2006"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/430352"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-014-0023-0"},{"key":"e_1_3_1_9_2","volume-title":"Package insert","author":"Merck & Co, Inc","year":"2003","unstructured":"Merck & Co, Inc. 2003. Cubicin (daptomycin). Package insert. Merck & Co, Inc, Whitehouse Station, NJ."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00095.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00019-10"},{"key":"e_1_3_1_12_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antimicrobial susceptibility testing, 30th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"30"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv076"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku455"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx214"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky439"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00636-09"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq193"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03600-14"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01242-06"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks006"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0449-9"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.07.005"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02371-13"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.07.024"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000191"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/655827"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.01.019"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02015-16"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0785-2"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz168"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.8.2557-2566.1997"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1747"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00487-10"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.2871-2875.2004"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01525-12"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir340"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00157-18"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01204-13"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2034"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw709"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002769"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ808"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz746"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0103"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01816-17"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.07.006"},{"key":"e_1_3_1_48_2","volume-title":"Package insert","author":"Forest Pharmaceuticals, Inc","year":"2011","unstructured":"Forest Pharmaceuticals, Inc. 2011. Teflaro (ceftaroline fosamil). Package insert. Forest Pharmaceuticals, Inc, St. Louis, MO."},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01516-09"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00797-12"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01586-12"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.061"},{"key":"e_1_3_1_53_2","first-page":"970","article-title":"A review on daptomycin; the first US-FDA approved lipopeptide antibiotics","volume":"2","author":"Nakhate PH","year":"2013","unstructured":"Nakhate PH, Yadav DVK, Pathak AN. 2013. A review on daptomycin; the first US-FDA approved lipopeptide antibiotics. J Sci Innovative Res 2:970\u2013980.","journal-title":"J Sci Innovative Res"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.11.2321"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02308-12"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00386-15"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku378"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000222"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0763-0"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01235-16"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2018.1448110"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02483-18"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00900-19"},{"key":"e_1_3_1_64_2","unstructured":"McCreary E Geriak M Zasowski E Rizvi K Schulz LT Ouellette K Vasina L Rybak MJ Zervos M Sakoulas G Rose W. 2018. Multi-centre cohort study of daptomycin plus ceftaroline combination compared to matched standard of care treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia abstr P2038. 28th Eur Congr Clin Microbiol Infect Dis Madrid Spain."},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-00277-2"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01304-7"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.12.005"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01554-17"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz538"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01666-15"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00468-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00468-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:47:27Z","timestamp":1645480047000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00468-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,6,23]]}},"alternative-id":["10.1128\/AAC.00468-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.00468-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"2020-06-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00468-20"}}